Literature DB >> 30097272

Impact of an emergency medicine pharmacist on empiric antibiotic prescribing for pneumonia and intra-abdominal infections.

Benjamin D Kulwicki1, Kasey L Brandt1, Lauren M Wolf1, Andrew J Weise2, Lisa E Dumkow3.   

Abstract

PURPOSE: It is critical to engage ED providers in antimicrobial stewardship programs (ASP). Emergency medicine pharmacists (EMPs) play an important role in ASP by working with providers to choose empiric antimicrobials. This study aimed to determine the impact of an EMP on appropriate empiric antibiotic prescribing for community-acquired pneumonia (CAP) and intra-abdominal infections (CA-IAI).
METHODS: A retrospective cohort study was conducted evaluating adult patients admitted with CAP or CA-IAI. The primary outcome of this study was to compare guideline-concordant empiric antibiotic prescribing when an EMP was present vs. absent. We also aimed to compare the impact of an EMP in an early-ASP vs. established-ASP.
RESULTS: 320 patients were included in the study (EMP n = 185, no-EMP n = 135). Overall empiric antibiotic prescribing was more likely to be guideline-concordant when an EMP was present (78% vs. 61%, p = 0.001); this was true for both the CAP (95% vs. 79%, p = 0.005) and CA-IAI subgroups (62% vs. 44%, p = 0.025). Total guideline-concordant prescribing significantly increased between the early-ASP and established-ASP (60% vs. 82.5%, p < 0.001) and was more likely when an EMP was present (early-ASP: 68.3% vs. 45.8%, p = 0.005; established-ASP: 90.5% vs. 73.7%, p = 0.005). Patients receiving guideline-concordant antibiotics in the ED continued appropriate therapy upon admission 82.5% of the time vs. 18.8% if the ED antibiotic was inappropriate (p < 0.001).
CONCLUSION: The presence of an EMP significantly improved guideline-concordant empiric antibiotic prescribing for CAP and CA-IAI in both an early and established ASP. Inpatient orders were more likely to be guideline-concordant if appropriate therapy was ordered in the ED.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emergency Department; Empiric antibiotics; Intra-abdominal; Pharmacist; Pneumonia; Stewardship

Mesh:

Substances:

Year:  2018        PMID: 30097272     DOI: 10.1016/j.ajem.2018.07.052

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Antibiotic dosing adjustments in hospitalized patients with chronic kidney disease: a retrospective chart review.

Authors:  Bahia Chahine
Journal:  Int Urol Nephrol       Date:  2021-03-18       Impact factor: 2.370

2.  A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2018.

Authors:  Elias B Chahine; Spencer H Durham; Krutika N Mediwala; Daniel B Chastain; Timothy P Gauthier; Brandon K Hill; Bruce M Jones; Jamie J Kisgen; Ashley H Marx; Kayla R Stover; Marylee V Worley; Christopher M Bland; P Brandon Bookstaver
Journal:  Open Forum Infect Dis       Date:  2019-10-15       Impact factor: 3.835

Review 3.  BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department.

Authors:  Maressa Santarossa; Emily N Kilber; Eric Wenzler; Fritzie S Albarillo; Ethan J Sterk
Journal:  Pharmacy (Basel)       Date:  2019-11-01

4.  PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study.

Authors:  Megan A Rech; William Adams; Keaton S Smetana; Payal K Gurnani; Megan A Van Berkel Patel; William J Peppard; Drayton A Hammond; Alexander H Flannery
Journal:  Crit Care Explor       Date:  2021-04-26

5.  The Clinical Pharmacist-Led Consultation for Infectious Diseases in Guizhou Province, China: A Survey Among Hospital Pharmacies.

Authors:  Jiaxing Zhang; Chang Xu; Wenyi Zheng; Rui He; Juan Xie; Xin Qian; Shijuan Xiong; Qi Chen
Journal:  Front Pharmacol       Date:  2020-02-27       Impact factor: 5.810

6.  COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department.

Authors:  Michael S Pulia; Ian Wolf; Lucas T Schulz; Aurora Pop-Vicas; Rebecca J Schwei; Peter K Lindenauer
Journal:  West J Emerg Med       Date:  2020-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.